BICO Group ABCLLKF -7.36%63 FCF Yield % is 1.30 as of Jun. 26, 2026. GuruFocus rates CLLKF with a GF Score™ of 63/100 and a GF Value™ of $3.69 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, BICO Group AB ranks better than 60.94% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
BICO Group AB FCF Yield % Related Terms
BICO Group AB FCF Yield % Historical Data
* Premium members only.
The historical data trend for BICO Group AB's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, BICO Group AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BICO Group AB FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where BICO Group AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BICO Group AB (CLLKF) has a FCF Yield % of 1.30 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on BICO Group AB and its competitors. According to the industry distribution chart, BICO Group AB ranks #334 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 39.1%.
Is BICO Group AB's FCF Yield % too high?
BICO Group AB's current FCF Yield % is 1.30. Based on the distribution chart, BICO Group AB ranks #334 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, BICO Group AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BICO Group AB ranks #334 out of 855 companies for FCF Yield %. This puts BICO Group AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on BICO Group AB and its competitors. BICO Group AB's current FCF Yield % is 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
Based on GuruFocus' analysis, BICO Group AB (CLLKF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.69, compared to a current price of $1.76 — trading 52.2% below its estimated fair value. The current FCF Yield % is 1.30. BICO Group AB's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For BICO Group AB (CLLKF), the current FCF Yield % is 1.30 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BICO Group AB (CLLKF) Overvalued in 2026?
Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued.
The current stock price of $1.76 is trading 52.2% below its estimated GF Value™ of $3.69.
GuruFocus considers BICO Group AB to be Possible Value Trap.
Key valuation signals for CLLKF:
FCF Yield %: 1.30
GF Value™: $3.69 vs. price of $1.76 (52.2% below fair value)
No single metric tells the full story. See the CLLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
63GF Score
Get the complete analysis for CLLKF
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLLKF has been successfully added to your 
